NASDAQ: BLRX       Biolinerx Ltd
Last Price Today's Change   Day's Range   Trading Volume
1.735   -0.205 (10.57%)  1.64 - 1.75  2,943,683


Avg Volume (4 weeks):683,157
4 Weeks Range:1.53 - 2.48
4 Weeks Price Volatility (%):
52 Weeks Range:0.29 - 4.75
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

BioLine Rx Ltd is a clinical-stage biopharmaceutical company, which is engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. It offers products such as BL-1020 which is used to improve cognitive function in schizophrenia patients; BL-1040 for the prevention of cardiac remodeling following an acute myocardial infarction; BL-5010, for non-surgical removal of skin lesions; BL-1021 for the treatment of neuropathic pain or pain that results from damage to nerve fibers, and BL-7040, a synthetic oligonucleotide, which is used for the treatment of inflammatory bowel disease. Geographically all the operations are functioned from the region of Israel.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3793  1863  378  2916 

Top 10 Active Counters
 CETX 2.38+1.433 
 VISL 0.385+0.091 
 AVP 5.60-0.05 
 DGLY 2.285+1.165 
 AESE 4.898+2.448 
 AABA 19.630.00 
 TGE 22.39+0.81 
 AKRX 0.09-0.094 
 PFE 35.065-3.125 
 OCGN 0.225-0.085 
Partners & Brokers